Physiological Flow of Liquids in Head and Neck Cancer Patients: A Pilot Study
3 other identifiers
observational
12
1 country
1
Brief Summary
This study is part of a larger grant, for which the overall goal is to collect measurements of liquid flow through the oropharynx (i.e., mouth and throat) during swallowing. The focus of this study is to evaluate the flow of liquids of varying consistency in the head and neck cancer population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 19, 2016
CompletedFirst Submitted
Initial submission to the registry
September 27, 2019
CompletedFirst Posted
Study publicly available on registry
October 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedResults Posted
Study results publicly available
July 13, 2022
CompletedApril 7, 2023
April 1, 2023
3 years
September 27, 2019
June 14, 2022
April 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants With Unsafe Swallowing
Swallowing safety was measured using the Penetration-Aspiration Scale, an 8-point categorical scale which captures the depth to which any material enters the airway and whether or not the material is ejected. Levels 1 and 2 on the scale are considered safe, while levels \> 2 are considered unsafe. Actual scale scores (1-8) will be recorded and then converted to binary categorical scores (\< 3 vs \>/= 3). We will report the frequency (count) of participants showing scores \> 2 by bolus consistency.
Baseline (single timepoint only)
Amount of Residue in the Pharynx
Residue is material remaining behind in the pharynx after the swallow. We measured residue by tracing the area of barium visible on a lateral view x-ray (in pixels, using ImageJ software) and dividing that area by the squared length C2-C4 cervical spine. This cervical spine scalar provides a common anatomical reference that is a proxy for pharyngeal size, and enables the comparison of residue severity across different people with different neck length and pharynx size. In healthy swallowing, residue is expected to be minimal. We report mean values and standard deviations for amount of residue by consistency (thin, slightly thick, and mildly thick liquids).
Baseline (single timepoint only)
Secondary Outcomes (1)
Number of Participants Reporting Dislike of Thickened Liquid Stimuli
Baseline (single timepoint only)
Study Arms (1)
Adults with oropharyngeal cancer
Adult participants who have completed radiation therapy for oropharyngeal cancer within the past 3 months will undergo a swallowing x-ray study in which they will swallow up to 15 liquid stimuli prepared to different consistencies using starch and gum based thickeners.
Interventions
Barium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.
Barium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.
Eligibility Criteria
Adults who have recently completed radiation treatment for oropharynx cancer at the University Health Network, Toronto.
You may qualify if:
- An initial cancer diagnosis of cancer in the base of tongue region of the oropharynx (Tumor staging T2,T3 \& T4; Nodal staging N0 orN1; Human Papilloma Virus + or -).
- Completion of bilateral radiation therapy to the neck 3 months prior to enrollment
- No longer requiring primary enteral feeding for nutrition.
You may not qualify if:
- Prior history of swallowing, motor speech, gastro#esophageal difficulties, chronic sinusitis or taste disturbance.
- Previous radiation to the head and neck (prior to current illness);
- Previous cancer diagnosis;
- Prior or planned neck dissection;
- Trachestomy in situ;
- Neurological difficulties unrelated to spinal disorder (e.g. Stroke, Parkinson disease, etc).
- Cognitive communication difficulties that may hinder ability to participate.
- Current use of mechanical ventilation
- Type 1 Diabetes (due to the requirement to swallow stimuli containing starch based thickeners, which carry a significant carbohydrate load).
- Known allergies to latex, food coloring or dental glue (due to the probability that these items will come into contact with the oral mucosa during data collection).
- Occupational exposure to radiation exceeding 10 mSv in the past 6 months.
- Current pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Health Network
Toronto, Ontario, M5G 2C4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Director, Swallowing Rehabilitation Research Laboratory
- Organization
- University Health Network
Study Officials
- PRINCIPAL INVESTIGATOR
Catriona Steele, PhD
KITE - Toronto Rehabilitation Institute, University Health Network
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2019
First Posted
October 2, 2019
Study Start
December 19, 2016
Primary Completion
December 31, 2019
Study Completion
March 30, 2021
Last Updated
April 7, 2023
Results First Posted
July 13, 2022
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
No plan at this time.